Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020)

Kymera Therapeutics (KYMR) has disclosed Preferred Dividend Payments for 1 consecutive years, with -$50000.0 as the latest value for Q2 2020.

  • Quarterly Preferred Dividend Payments changed N/A to -$50000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2020, changed N/A year-over-year, with the annual reading at $9.0 million for FY2020, N/A changed from the prior year.
  • Preferred Dividend Payments for Q2 2020 was -$50000.0 at Kymera Therapeutics, down from $9.1 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $9.1 million in Q1 2020, with the low at -$50000.0 in Q2 2020.